Indian Railways Manigram-Nimtita Section Electrified: All You Need To Know
Indian Railways Manigram-Nimtita Section: Railway Minister Piyush Goyal inaugurated the newly electrified Manigram-Nimtita section of the Eastern Railways zone, along with other railway infrastructure projects in the region. The 34 km long Manigram-Nimtita section of the Eastern Railway zone has been electrified at a cost of Rs.52.05 crore. The electrification will help in reducing the carbon footprint and will support green energy for the railway zone. The Railway Minister also flagged off goods train on newly electrified Manigram-Nimtita section which is likely to provide a significant boost to the thermal industrial plants around the region. (Also Read: Capex Utilisation In Dedicated Freight Corridor Project Increases 21% To ₹ 8,201 Crore )
The electrification work is a part of the high utility network, or 'Sagar Purvodaya Sampark Line' from Howrah to Dibrugarh, according to the Railway Ministry. A road under bridge near Malda and Manigram, five foot overbridges at Khagraghat road, Lalbagh Court road, Tenya, Dahaparadham and Niyalishpara stations, and two foot overbridges at Sujnipara and Basudebpur stations, were inaugurated under Eastern Railway's Malda Division through video conferencing on Wednesday, February 17.Â
The electrified Manigram-Nimtita section will help in switching over freight rake destined for the Sagardighi Thermal Power Plant as well as the Sonar Bangla Cement Plant from diesel to electric traction. It will also support the for the conversion of passenger trains from diesel-electric multiple unit (DEMU) to mainline electric multiple unit (MEMU) in the section. It will also save diesel and will contribute to the industrial development of the area.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.